WACKER raises Full-Year Forecast after another strong quarter


Wacker Chemie AG continued on its growth trajectory in Q2 2022. The Munich-based chemical company generated sales of €2,174.2M in the reporting quarter (Q2 2021: €1,501.0M), up by 45% yr-on-yr. Relative to the preceding quarter (€2,076.2M), sales were up by 5%, benefiting from product-mix and volume effects, as well as from the yr-on-yr rise in the US dollar. All four business divisions contributed to this sales growth. Polysilicon performed particularly well, with sales increasing by 68% yr-on-yr, due to higher prices. The two chemical divisions – WACKER SILICONES and WACKER POLYMERS – each grew by more than 40% and demand was particularly strong, for example, for products used in adhesives and industrial coatings. Business in biotechnological products and fine chemicals also showed solid growth, with sales up by 16%.

EBITDA (earnings before interest, taxes, depreciation and amortisation) totalled €625.8M in Q2 2022, almost double the figure of a year earlier (€320.9M). Here, again, improved prices and product-mix effects were key growth drivers. Very high plant-utilisation rates also had a positive impact on EBITDA. On the other hand, significantly higher energy and raw-material prices had a negative effect. They were also the reason for a slight decline in EBITDA compared with a quarter earlier (€643.7M). WACKER’s reporting-quarter EBITDA margin was 28.8% (Q2 2021: 21.4%). The margin in the preceding quarter was 31.0%.

Reporting-quarter EBIT (earnings before interest and taxes) came in at €528.5M, more than doubling year over year (Q2 2021: €228.0M). That corresponded to an EBIT margin of 24.3% (Q2 2021: 15.2%). Relative to Q1 2022 (€549.5M), EBIT was slightly lower. Depreciation and amortisation amounted to €97.3M in the second quarter (Q2 2021: €92.9M). Net income for the period totalled €390.9M (Q2 2021: €173.2M), corresponding to earnings per share of €7.67 (Q2 2021: €3.39).

Despite significant risks to the global economy – due in particular to the impact of the war in Ukraine, but also to the ongoing coronavirus pandemic – WACKER expects to continue growing. The company raised its forecast for full-year 2022 and now expects to post sales of between €8.0bn and €8.5bn (previous guidance: €7.5bn). Full-year EBITDA is likely to come in between €1.8bn and €2.3bn (previous guidance: between €1.2bn and €1.5bn). Higher energy and raw-material costs are likely to impact EBITDA by around €1.5bn (previous guidance: €1.1bn). The current forecast takes this into account.

If major restrictions in the supply of natural gas were to arise in the course of the year, effects on WACKER’s production cannot be ruled out, as is the case for many other industrial companies. For this reason, WACKER has taken the precaution of factoring in a further €200–250M in additional costs at the lower end of its EBITDA forecast, on top of the energy and raw-material price increases already taken into account. Without this additional cost burden, full-year EBITDA of between €2.0bn and €2.3bn is possible in 2022.

“In the second quarter, WACKER continued on its growth trajectory in an increasingly challenging environment. Our quarterly sales were the highest in our company’s history. Earnings almost doubled year over year, as we were able to offset a large portion of our substantially higher energy and raw-material costs by raising our prices,” said CEO Christian Hartel in Munich on Thursday. “However, we are increasingly concerned about the unabated price hikes for energy and raw materials. Added to that is uncertainty regarding future natural gas supplies,” said Hartel. The German government had already invoked Phase 2 of its emergency gas plan, he said. “This has not affected our production as yet. However, we have been working on solutions for various scenarios since February,” explained Hartel. He went on to say that the current geopolitical crises, first and foremost the war in Ukraine, would also give rise to significant risks, as would the ongoing coronavirus pandemic – and then there was rising inflation. “It not only pushes up our own production costs, but also strongly influences consumer behaviour – and, in turn, our business.” Hartel was nonetheless upbeat about future business development: “The positive trend in selling prices and the strong demand we are currently seeing in our customer sectors allow us to look to the second half of the year with confidence – despite current uncertainty.”

Hartel was also optimistic as regards WACKER’s medium-term prospects: “Our solid business performance reflects customer confidence in WACKER’s products and technologies. It demonstrates that we are well on track to achieve our growth targets.” As part of its growth strategy, WACKER is focusing on specialty products in its chemical divisions and scaling up its biotechnology activities. When it comes to polysilicon, the company is concentrating on its goal of increasing the share of hyperpure semiconductor-grade polysilicon in its portfolio. The goal is to increase Group sales to more than €10bn by 2030, while still maintaining high profitability.

“In order to accelerate growth, we are focusing our investment spending on expanding capacity and on developing new products and applications,” said Hartel. “In recent months, we have launched a whole series of projects. At our plant in Holla, Norway, we are getting ready to expand our production capacity for silicon metal. We have opened a new production plant at Panagarh in India to meet burgeoning demand for silicone rubber. We are also expanding silicone production capacity at our Burghausen site. We opened a regional Innovation Center in the USA, where we will develop biotech and silicone specialty products for high-tech applications. In Munich, we commenced construction of a research centre for biotech activities. At our site in Halle, an mRNA technical competence centre is taking shape. When it is completed in 2024, mRNA vaccines are among the products we will be able to manufacture there. At this site alone, we are investing more than €100M.”

Regions
In Q2 2022, WACKER’s sales increased year over year in every region, mainly due to higher selling prices. Sales in Asia rose to €944M, up by about 52% from the year-earlier figure (Q2 2021: €620M). Sales in the Americas totalled €348M (Q2 2021: €211M), up by a robust 65% yr-on-yr. Reporting-quarter sales in Europe totalled €767M (Q2 2021: €595M), up by 29% versus a year earlier.

Capital Expenditures and Net Cash Flow
In Q2 2022, the Group’s capital expenditures came in at €99.7M (Q2 2021: €68.2M), up by 46% yr-on-yr. Funds were invested primarily in expanding silicones capacity, but also in increasing capacity for polymer products and biologics.

Net cash flow was €96.4M in the reporting quarter, after €208.2M in the same period last year, due in part to the sales-related increase in working capital and to higher capital expenditures.

Employees
WACKER’s global workforce grew in the reporting quarter. The Group had 15,250 employees on June 30, 2022 (March 31, 2022: 14,595). At the end of the quarter, 10,151 employees worked at WACKER sites in Germany (March 31, 2022: 10,111) and 5,099 at international locations (March 31, 2022: 4,484).

Outlook
WACKER detailed its projections for the Group’s performance this year in the Outlook section of its 2021 Annual Report.

In view of the positive business trend, the company had already revised its sales forecast upward on presentation of its figures for Q1 2022. On June 13, 2022, WACKER announced that, based on its then-current estimates, it expected to post EBITDA of around €600M and sales of around €2.1bn in Q2 2022. WACKER also announced that it would revise upward its guidance for full-year 2022.

The company now expects to post full-year sales of between €8.0bn and €8.5bn (previous guidance: €7.5bn). Full-year EBITDA is likely to come in between €1.8bn and €2.3bn (previous guidance: between €1.2bn and €1.5bn). These higher expectations are the result of the continuing positive trend in selling prices and unabated strong demand in numerous customer sectors. Higher energy and raw-material costs are likely to impact EBITDA by around €1.5bn (previous guidance: €1.1bn). Our current forecast takes this into account. Given the uncertainty surrounding future natural gas supplies, WACKER has also taken the precaution of factoring in a further €200–250M in additional costs at the lower end of its EBITDA forecast, on top of the energy and raw-material price increases already taken into account. Without this additional cost burden, full-year EBITDA of between €2.0bn and €2.3bn is possible in 2022.

The new forecast for EBITDA also changes the estimate for the full-year EBITDA margin, which is now expected to be roughly on par with last year (previous guidance: substantially lower than last year). Group net income for the year is now expected to be substantially higher than the previous year (previous guidance: substantially lower than last year). Guidance for the remaining financial KPIs remains unchanged versus the forecasts made in the 2021 Annual Report.


Share this page
  • Editorial Programme

    Coming up in the August 2022 issue

    • Antimicrobial Coatings
    • FEICA Preview
    • Middle East Coatings Show Review
    • Protective Coatings
    • Resins
    • SURFEX Review
    • Test & Weathering Equipment

    Publication date: Fri 26th Aug 2022
    Editorial deadline: Mon 8th Aug 2022
    Advertising deadline: Mon 8th Aug 2022

    For information on forthcoming editorial features and deadlines please click here.

Sister publication